245 completed, 20 terminated, 19 recruiting, 19 unknown. 114 Not applicable, 44 Phase 1, 43 Phase 2, 34 Phase 4, 27 Phase 3.
Follow Human Immunodeficiency Virus: new trials by email Literature Review of Human Immunodeficiency Virus trials Research Report on Human Immunodeficiency Virus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PositiveLinks for Youth (PL4Y) for Texas PositiveLinks for Youth Smartphone App - Human Immunodeficiency Virus, HIV | Not applicable | Not yet recruiting | The University of Texas Health Science Center at San Antonio | 600 | 2027-04-01 | 2026-09-04 |
| Medical Mistrust Among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex With Men (HLMSM) Navigators (peer navigator) training, delayed-intervention - Human Immunodeficiency Virus | Not applicable | Not yet recruiting | Wake Forest University Health Sciences | 144 | 2027-03-01 | 2026-04-30 |
| Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study No Marginal Cost Interventions, Low-Marginal Cost Interventions, Standard of Care - Human Immunodeficiency Virus | Not applicable | Not yet recruiting | Emory University | 223165 | 2027-03-01 | 2026-09-16 |
| Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV Dose Level 1 ACU-D1 ointment, Dose Level 2 ACU-D1 ointment, Dose Level 3 ACU-D1 ointment - Human Papilloma Virus, Human Immunodeficiency Virus | Phase 1 | Not yet recruiting | Emory University | 9 | 2026-12-01 | 2026-08-18 |
| HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong ICVAX (TERESA-EPT I device), ICVAX (PharmaJet Tropis device), ICVAX (TriGrid device) - Human Immunodeficiency Virus, Human Immunodeficiency Virus I Infection | Phase 1 | Recruiting | Immuno Cure Holding (HK) Limited | 22 | 2026-03-30 | 2026-04-15 |
| Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy Lenacapavir - Human Immunodeficiency Virus | Phase 1 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 50 | 2026-01-20 | 2026-10-15 |
| Universal Test and Connect for HIV Service Delivery in South Africa HIV testing, In-depth interview - Human Immunodeficiency Virus, Pre-Exposure Prophylaxis | Recruiting | Johns Hopkins University | 2000 | 2026-01-19 | 2026-01-30 | |
| The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care SUSTAIN-DSD, Enhanced (guideline-driven) Standard of Care (E-SoC) - Human Immunodeficiency Virus | Not applicable | Recruiting | Brigham and Women's Hospital | 310 | 2025-11-14 | 2025-11-24 |
| The Eswatini PRISM Study on Adolescents Living With HIV Promoting Resilience in Stress Management intervention - Human Immunodeficiency Virus, Psychological Stress | Not applicable | Active not recruiting | Eswatini Nazarene Health Institutions | 140 | 2025-10-30 | 2026-10-02 |
| Impact of NMN Supplementation on CD4+ T Cell Recovery in HIV Patients With Immunological Failure Nicotinamide Mononucleotide - Human Immunodeficiency Virus | Not applicable | Not yet recruiting | TriHealth Inc. | 7 | 2025-04-01 | 2025-04-03 |
| Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya Artesunate vaginal inserts, Placebo vaginal inserts - Human Immunodeficiency Virus, Human Papillomavirus | Phase 2 | Completed | UNC Lineberger Comprehensive Cancer Center | 120 | 2025-01-22 | 2026-05-14 |
| Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium Human Immunodeficiency Virus | Recruiting | Belgian Research on AIDS and HIV Consortium | 600 | 2025-01-13 | 2025-02-05 | |
| Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH) Biospecimen Collection, Questionnaires - Human Immunodeficiency Virus, Human Papillomavirus-Related Anal Squamous Cell Carcinoma | Active not recruiting | University of California, San Francisco | 217 | 2024-10-31 | 2026-08-20 | |
| Computerized Cognitive Rehabilitation of Patients With Cognitive Deficits Due to the Human Immunodeficiency Virus Computerized Gaming Rehabilitation Program 1, Computerized Gaming Rehabilitation Program 2 - Human Immunodeficiency Virus, Cognitive Dysfunction | Not applicable | Unknown | Centre Hospitalier Universitaire Vaudois | 24 | 2024-10-01 | 2024-09-19 |
| Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study Collaborative Care Model - Human Immunodeficiency Virus, Mental Disorder | Not applicable | Recruiting | University of Colorado, Denver | 900 | 2024-10-01 | 2026-10-08 |
| Data Science and Qualitative Research for Decision Support in the HIV Care Cascade Activation of the CDSS system - Human Immunodeficiency Virus, Treatment Adherence | Not applicable | Enrolling by invitation | Brown University | 80000 | 2024-05-20 | 2026-01-12 |
| Mobile-health (mHealth) Intervention to Support HIV Self-testing and PrEP Uptake Among Young Men Who Have Sex With Men IMB, Information-Only Control - Human Immunodeficiency Virus | Not applicable | Completed | Medical College of Wisconsin | 118 | 2024-03-21 | 2026-05-01 |
| Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection 4 week prebiotic consumption, 4 week placebo consumption - Alcohol Use Disorder, Human Immunodeficiency Virus | Not applicable | Recruiting | Rush University Medical Center | 40 | 2024-03-05 | 2026-06-04 |
| Human Immunodeficiency Virus Pre-exposure Prophylaxis Program in General Practice PrEP in general practice - Human Immunodeficiency Virus | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 400 | 2024-02-15 | 2024-02-14 | |
| Support for Adolescents Living With HIV in South Africa In-person adolescent-friendly service (iPAS) intervention, mHealth (InTSHA) intervention, Standard of Care - Human Immunodeficiency Virus, HIV | Not applicable | Active not recruiting | Emory University | 570 | 2024-02-02 | 2026-03-09 |
Showing 20 of 328. Sign in to see all of them.
Acquired Immunodeficiency Syndrome (328) · HIV Infections (26) · Hepatitis C (20) · Substance-Related Disorders (12) · Sexually Transmitted Diseases (10) · Depression (9) · Tuberculosis (9) · Psychological Well-Being (7) · Hepatitis B (6) · Hepatitis C, Chronic (6) · Opioid-Related Disorders (6) · Alcoholism (5) · Anxiety Disorders (5) · Immunologic Deficiency Syndromes (4) · Infections (4)
Blood-Borne Infections (328) · Genital Diseases (328) · Slow Virus Diseases (328) · Urogenital Diseases (328) · Lentivirus Infections (327) · Retroviridae Infections (327) · Sexually Transmitted Diseases, Viral (327) · Virus Diseases (327) · Communicable Diseases (326) · Immune System Diseases (326) · Immunologic Deficiency Syndromes (324) · Infections (324) · RNA Virus Infections (324) · Sexually Transmitted Diseases (318) · HIV Infections (302)
Raltegravir Potassium (10) · Standard of Care (9) · dolutegravir (8) · Ritonavir (7) · Tenofovir (7) · lopinavir-ritonavir drug combination (7) · Emtricitabine (6) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (6) · Maraviroc (6) · Surveys and Questionnaires (6) · Antibodies, Monoclonal (5) · Blood Specimen Collection (5) · Lopinavir (5) · Lamivudine (4) · Sofosbuvir (4)
Emory University (13) · University of California, San Francisco (10) · University of North Carolina, Chapel Hill (10) · Johns Hopkins University (7) · University of Pennsylvania (7) · Yale University (7) · International Partnership for Microbicides, Inc. (6) · Rockefeller University (6) · Columbia University (5) · Merck Sharp & Dohme LLC (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · University of California, Los Angeles (5) · University of Colorado, Denver (5) · University of Miami (5) · AbbVie (prior sponsor, Abbott) (4)
United States (147) · South Africa (26) · Kenya (19) · Canada (16) · Uganda (14) · United Kingdom (12) · Spain (11) · France (9) · Italy (9) · Belgium (7) · Germany (7) · China (6) · Mexico (6) · Puerto Rico (6) · Brazil (5)
Harsha Thirumurthy, PhD (6) · Marina Caskey, MD (4) · Lisa Abuogi, MD, MSc (3) · Sebastian Linnemayr, PhD (3) · Anuj Gaggar, MD, PhD (2) · Audrey Pettifor (2) · Awewura Kwara, MD (2) · Bart Rijnders, MD, PhD (2) · Chemtai Mungo, MD, MPH (2) · Corina Lelutiu-Weinberger, PhD (2) · Faye Taxman, PhD (2) · Fu-Sheng Wang, Professor (2) · Jacob Lalezari, MD (2)
PMID 32838558, PMID 25583164, PMID 35358290, PMID 36146760, PMID 41830320, PMID 15995950, PMID 16870053, PMID 18495540, PMID 20010070, PMID 20146631, PMID 20608766, PMID 21150868, PMID 21205302, PMID 21535876, PMID 21767228, PMID 21850488, PMID 21903660, PMID 22048728, PMID 22913681, PMID 23251327, PMID 23351187, PMID 23473847, PMID 23748182, PMID 23925377, PMID 23946220, PMID 24097843, PMID 24382064, PMID 24465444, PMID 24469222, PMID 24535278, PMID 24674234, PMID 25014688, PMID 25038354, PMID 25659285, PMID 25785969, PMID 26231855, PMID 26396157, PMID 26418084, PMID 26560326, PMID 26614966, PMID 26644132, PMID 26666313, PMID 26689767, PMID 26707828, PMID 26731175, PMID 26743093, PMID 27064996, PMID 27175676, PMID 27308805, PMID 27527002
2019 (2), 2023 (2), P01AI074340 (2), R01DA030768 (2), R01HD071779 (2), R01HD083033 (2), U01AI145921 (2), 2008 (1), 2014 (1), 2017 (1), 2018 (1), 5UM1AI068633-07 (1), D43TW009343 (1), K01DA036411 (1), K01TW009998 (1)